Klebsiella pneumoniae bacteremic cellulitis following tocilizumab administration for COVID-19
Takahiro Hase
Department of Dermatology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan
Search for more papers by this authorCorresponding Author
Ken Muramatsu
Department of Dermatology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan
Correspondence
Ken Muramatsu, Department of Dermatology, Faculty of Medicine and Graduate School of Medicine Hokkaido University, North 15 West 7, Kita-ku, Sapporo 060-8638, Japan.
Email: [email protected]
Search for more papers by this authorChihiro Shiiya
Department of Dermatology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan
Search for more papers by this authorChiho Shibusa
Department of Dermatology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan
Search for more papers by this authorHideyuki Kosumi
Department of Dermatology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan
Search for more papers by this authorJunichi Nakamura
Department of Respiratory Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan
Search for more papers by this authorTaku Maeda
Department of Plastic and Reconstructive Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan
Search for more papers by this authorHideyuki Ujiie
Department of Dermatology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan
Search for more papers by this authorTakahiro Hase
Department of Dermatology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan
Search for more papers by this authorCorresponding Author
Ken Muramatsu
Department of Dermatology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan
Correspondence
Ken Muramatsu, Department of Dermatology, Faculty of Medicine and Graduate School of Medicine Hokkaido University, North 15 West 7, Kita-ku, Sapporo 060-8638, Japan.
Email: [email protected]
Search for more papers by this authorChihiro Shiiya
Department of Dermatology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan
Search for more papers by this authorChiho Shibusa
Department of Dermatology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan
Search for more papers by this authorHideyuki Kosumi
Department of Dermatology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan
Search for more papers by this authorJunichi Nakamura
Department of Respiratory Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan
Search for more papers by this authorTaku Maeda
Department of Plastic and Reconstructive Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan
Search for more papers by this authorHideyuki Ujiie
Department of Dermatology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan
Search for more papers by this author
REFERENCES
- 1Hirano T, Murakami M. COVID-19: a new virus, but a familiar receptor and cytokine release syndrome. Immunity. 2020; 52: 731–733.
- 2Kuwahara M, Kamigaito M, Nitta S, Hasegawa K, Murakami H, Kobayashi T, et al. Effect of tocilizumab treatment on patients with coronavirus disease 2019 and bacteremia: a retrospective cohort study. Infect Dis Ther. 2022; 11: 533–541.
- 3Ippolito M, Simone B, Filisina C, Catalanotto F, Catalisano G, Marino C, et al. Bloodstream infections in hospitalized patients with COVID-19: a systematic review and meta-analysis. Microorganisms. 2021; 9:2016.
- 4Buetti N, Tabah A, Loiodice A, Ruckly S, Aslan AT, Montrucchio G, et al. Different epidemiology of bloodstream infections in COVID-19 compared to non-COVID-19 critically ill patients: a descriptive analysis of the Eurobact II study. Crit Care. 2022; 26: 319.
- 5Park HS, Lee UH, Choi JC, Chun DK. Klebsiella pneumoniae cellulitis in an immunocompetent man. J Am Acad Dermatol. 2004; 51: 836.
